No Data
No Data
Do Queasy Side Effects Mean the End of Weight-loss Drug Stock Hype?
Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now.
Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics
Viking Therapeutics: A Bad Result for Roche's Weight-Management Pill Is Great News for Oral VK2735
Top Gap Ups and Downs on Thursday: SNY, DEO, GOLD and More
Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?
No Data
No Data